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http:WHAT THIS PAPER ADDS
This study of AAA repair reports nationwide results from 2007 to 2010. It supplies more recent results than the
existing register studies and may reﬂect the improvements over time in stent-graft design and operator pro-
ﬁciency. Furthermore, we report detailed information on late outcomes after open aneurysm repair that are
seldom reported and which show a higher total frequency of procedure-related complications after OR than
EVAR. Our ﬁndings support recent reports that demographics rather than type of procedure cause the difference
in long-term mortality and corroborate the notion that endovascular treatment of AAA is not as inferior in the
long run as the early randomized controlled trials reported.Objective: To assess outcomes after treatment for asymptomatic abdominal aortic aneurysm (AAA) in Denmark
in a period when both open surgery (OR) and endoluminal repair (EVAR) have been routine procedures.
Methods: We performed a retrospective nationwide cohort study of patients treated for asymptomatic AAA
between 2007 and 2010. Data on demographics, procedural data, perioperative complications, length of stay
(LOS), 30-day reinterventions and readmissions, late aneurysm and procedure-related complications and
mortality were obtained from the Danish Vascular Registry and the Danish National Patient Register.
Results: 525 EVAR and 1176 OR for asymptomatic AAA were identiﬁed. LOS was shorter after EVAR than OR (4 vs.
7 days, p < .001). During primary hospitalization procedure-related complications (12% vs. 6%) and general
complications (21% vs. 8%) were more common after OR than EVAR (p < 0.001). The 30-day reintervention rate
was higher for OR than EVAR (18% vs. 6%, p < 0.001), but there was no difference in readmissions within 30
days. During follow-up (mean 29  15 months) aneurysm-related complications after EVAR were outweighed by
procedure-related complications after OR.
Conclusion: Elective AAA repair in Denmark is overall comparable with international results and both
perioperative and late outcomes after EVAR of elective AAA are better than the results after OR.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovascular aortic repair (EVAR) is a well-established mini-
mally invasive procedure for abdominal aortic aneurysm (AAA)
repair1 and offers a reduction in postoperative complications2
compared with open surgery (OR, open repair). Also, a
reduced hospital length of stay (LOS)2e4 and 30-day mortality
(0e2% vs. 2e5%) have been reported.2e6 However, late
aneurysm-related complications (13% vs. 3%)7 and rupture
rates (2% vs. 0.5%)2 have been reported to be higher for EVARrresponding author. L. de la Motte, Department of Vascular
, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9,
openhagen, Denmark.
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//dx.doi.org/10.1016/j.ejvs.2013.04.020than for OR. In the long-term, reinterventions for aneurysm-
related complications were more common after EVAR than
after OR,2,7 whereas the rate of surgery for laparotomy-related
complications was lower after EVAR than after OR.2 Hospi-
talization without surgery for laparotomy-related complica-
tions was also lower after EVAR than after OR.2 In the early
reports the beneﬁt from EVAR on survival rates was offset
after 2e4 years.2,3,7 However, recently published reports show
similar long-term survival after EVAR and OR.8,9
Previously published data are based on studies per-
formed between 1999 and 2008 involving use of older
generation devices. Current stent grafts are more reﬁned
with lower proﬁle and more suitable for adverse anatomy
and offer less traumatic and more precise deployment.
These technical improvements coupled with increasing
endovascular proﬁciency should be associated with better
outcomes, potentially making the reported results from
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(RCTs) outdated.10
The endovascular treatment of AAAs is centralized to
three departments and has been a treatment option in
Denmark since 1996. In total, 763 endovascular procedures
for both symptomatic and asymptomatic aneurysms were
performed from 1996 to 2010. In comparison 8482 aneu-
rysms were treated by open repair (performed at 8 de-
partments) in the same period.11
The aim of this study was to assess recent outcomes after
endovascular repair of asymptomatic AAA in Denmark and
to compare these results with open aneurysm repair in
Denmark.MATERIALS AND METHODS
We obtained nationwide data on patients treated electively
for an asymptomatic AAA between January 1, 2007, and
December 31, 2010. Data were primarily retrieved from the
Danish Vascular Registry a validated database of prospec-
tively collected data on all procedures performed at
vascular surgical departments in Denmark.12 A manual
search on each individual patient using their unique social
security number was done to match the prospective data
from the Danish Vascular Registry with data from the
Danish National Patient Register (LPR).
By combining output from the two registries we recorded
data on demographic characteristics, procedural data,A
*Diagnostic code according to the International Classification of Diseases, Tenth Revision (ICD10) and procedural 
codes according to the Nordic Classification of Surgical Procedures.
DI71.4 abdominal aortic aneurysm without mention of rupture, PDQ10 Insertion of stent into infrarenal abdominal aorta, 
PDG10 Operation on infrarenal abdominal aorta for aneurysm, PDG20 Bypass from aorta to iliac artery for aneurysm, 
PDG21 Bypass from aorta to bilateral iliac arteries for aneurysm, PDG22 Bypass from aorta to iliac and contralateral 
femoral artery for aneurysm, PDG23 Bypass from aorta to femoral artery for aneurysm, PDG24 Bypass from aorta to 
bilateral femoral arteries for aneurysm, PCG10 Operation for aneurysm of supracoeliac or juxtarenal abdominal aorta.
B
549 patients
Diagnostic code DI714* 
and elective procedure
and procedural code PDQ10* 
and year of procedure 2007– 2010 
Excluded: 5 
previous procedural code 
PDQ10*
537 patients
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1 redo (EVAR 2006) 
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and
Figure 1. Flowchart of cohort identiﬁcation. Endovascular repair
EVAR ¼ endovascular aortic repair.complications, length of stay (LOS), 30-day reinterventions
and readmissions, late aneurysm, and procedure-related
complications and mortality. Results are reported by
intention-to-treat. Data were censored at the end of October
2011.The ﬂowchart of cohort identiﬁcation is shown in Fig. 1.
The perioperative period was deﬁned as the ﬁrst 30 days
from the date of primary surgery.
LOS was deﬁned as the period from surgery to hospital
discharge e reported in days.
The American Society of Anesthesiologists (ASA) score
consists of four categories, but based on a previous study
we have compressed it to a binary score to achieve a higher
reliability.13
General (“medical”) complications were deﬁned as
moderate to severe affection of lungs, heart or kidneys
(acute tubular necrosis and/or dialysis), MODS (multiorgan
dysfunction syndrome), compartment syndrome, stroke,
pulmonary embolism, deep venous thrombosis or >3 days
stay in an ICU (intensive care unit).
Surgical complications were deﬁned as bleeding, bowel
ischemia, bowel obstruction, embolization, nerve lesion, or
rupture of the abdominal fascia.
Wound complications were deﬁned as hematoma,
wound infection, lymphorrhea, lymphocele, or sloughing
wound edges (wound necrosis).
Thirty-day reinterventions and readmissions are for all
causes not just procedure related. Reinterventions, read-
missions, and rates of complications were based on number1190 patients
Diagnostic code DI714* 
and elective procedure
 procedural code PDG10/ PDG20, PDG21/ PDG22/ 
PDG23/ PDG24/ PCG10* 
and year of procedure 2007– 2010 
Excluded: 7 
previous procedural code PDG10/ 
PDG20/PDG21/ PDG22/ PDG23/ PDG24 or 
PCG10*
1189 patients
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diagnostic code ≠ DI714*
1187 patients
Excluded: 2 
Acute procedure 
1180 patients
1176 patients
OR for an asymptomatic AAA from 
2007– 2010
Excluded: 4 
1 double registration 
2 converted from EVAR 
1 previous PDQ10* (EVAR) 
(A), open repair (B). AAA ¼ abdominal aortic aneurysm;
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type of event.
Acute kidney injury (AKI) following intervention was
deﬁned as impaired renal function and/or dialysis in pa-
tients without a preoperative diagnosis of renal impair-
ment. However, perioperative need for dialysis in patients
with preoperative renal impairment was recorded. The
Danish Vascular registry does not provide a strict plasma
creatinine limit deﬁning AKI but use the deﬁnition “an in-
crease in creatinine, rendering nephrological expertise
necessary or affecting the postoperative course.” Late dial-
ysis was deﬁned as continuous need for dialysis more than
12 months after the procedure.
Peripheral arterial disease (PAD) was deﬁned as the post-
operative onset of acute lower limb ischemia or claudication.
According to the reporting standards for EVAR endoleak
was deﬁned by the persistence of blood ﬂow outside the
endoluminal graft but within the aneurysm sac. The type of
endoleak is not recorded and only endoleaks that require
treatment are registered in the Danish Vascular Registry. In
Denmark follow-up with imaging (computed tomography
and duplex ultrasound) after EVAR is performed at 3
months, 12 months, and yearly thereafter.
Bowel ischemia, incisional hernia, and bowel obstruction
were recorded if no diagnosis or abdominal surgery had
been registered prior to the aneurysm procedure. Other
abdominal complications compress explorative laparot-
omies, iatrogenic bowel lesions, and intra-abdominal
abscesses.
Major aneurysm-related reinterventions included open or
endovascular procedures for rupture/anastomotic rupture,
open procedure for endoleak, revision of open repair, or an
axillobifemoral or unifemoral bypass with or without
resection of the old prosthesis.
Cause of death is registered for in-hospital deaths in the
Danish National Patient Register but is seldom veriﬁed by
autopsy. Therefore, we report all-cause mortality.
The study was registered with the Danish Data Protection
Agency ref. no. 2007-58-0015 and approved by the board of
the Danish Vascular Registry.Statistics
We compared the characteristics of the two groups by using
the ManneWhitney U test for continuous data and cross-
table methods with the Fisher exact test for dichotomous
categorical variables.
Survival rates were calculated using the KaplaneMeier
method for survival curves and the log-rank test for com-
parison of KaplaneMeier curves. Curves have been trim-
med at 50 months to obtain more reliable tests. Cox
regression was performed to test the independent effects of
baseline patient characteristics. Applying a signiﬁcance level
of 0.1 we included gender, age, hypertension, cardiac
morbidity, pulmonary morbidity, cerebral morbidity, cancer,
diabetes, baseline creatinine, and ASA score, apart from
EVAR and OR, in the multivariate analysis by forward
stepwise selection.A p value <0.05 (two-tailed) was considered to indicate
statistical signiﬁcance.We used the Bonferroni correction to
compensate for multiple testing.14RESULTS
There were 525 patients who underwent elective EVAR and
1176 patients who underwent elective open repair for
asymptomatic AAA from 2007 to 2010 (Fig. 1). Two EVAR
patients (0.4%) were intraoperatively converted to open
repair. The mean follow-up was 29.1  15.0 months.
Patients treated with the endovascular technique were
older and more often males than the patients treated by
open repair (Table 1). The EVAR patients also had a higher
ASA score, reﬂecting the higher rates of cardiac and pul-
monary morbidity than the OR patients (Table 1). Preop-
erative renal status did not differ in the two cohorts
(Table 1). The duration of the endovascular procedure was
on average shorter and the EVAR patients were discharged
signiﬁcantly earlier than the patients treated by OR
(Table 1). In addition the OR patients were more often
discharged to another hospital department (11% vs. 5%)
(p < 0.001).
There was a higher rate of both general and surgical
complications after OR than after EVAR (Table 2), but
wound complications were signiﬁcantly more frequent after
EVAR than after OR (Table 2). However, 28 (15%) out of 190
patients treated with an open aortobifemoral procedure in
the OR cohort had wound complications similar to the rate
of wound complications after EVAR 14% (p ¼ 0.9).
Perioperative AKI was seen in 13 EVAR patients; of these,
three patients were in need of dialysis. Both ﬁgures were
signiﬁcantly lower than for OR, where 39 out of 81 patients
with perioperative AKI required dialysis (Table 2). There
were high mortality rates related to perioperative dialysis,
EVAR 33%, and OR 38% (p ¼ 1.0). After 3 months one EVAR
and seven OR patients still required dialysis. However, three
out of seven OR patients gained remission within 12
months, and late dialysis was recorded in one EVAR and
four OR patients (Table 3).
Postoperative onset of lower limb ischemic symptoms
(onset PAD) was seen in 11 patients after EVAR and 37
patients after OR (Table 2). In nine (1.7%) of the EVAR
patients and 27 (2.3%) of the OR patients it was critical limb
ischemia that required acute intervention (p ¼ 0.6). In
addition, one EVAR patient and 15 OR patients with known
PAD underwent acute intervention for critical limb ischemia
after the procedures.
Thirty-day reinterventions were more common after OR,
whereas readmissions within 30 days were equally frequent
(Table 2). Most reinterventions after EVAR were groin
related (66%), comprising 38% hematomas/bleeding from
the groin, 16% wound infections/necrosis, and 12%
lymphocele.
Thirty-day mortality was lower after EVAR than after OR
(Table 2), but at 1 year the advantage was offset by an
increase in mortality in the EVAR cohort (EVAR 6.1% vs. OR
7.7%, p ¼ 0.26). By 2 years, mortality was higher after EVAR
Table 1. Patient characteristics and operative data.
EVAR (n ¼ 525) OR (n ¼ 1176) p Valuea
Gender (male) 474 (90) 941 (80) <0.001
Age (years) 74 (69e78) 70.5 (66e75) <0.001
Smokingb 446 (85) 984 (84) 0.5
Hypertension 329 (63) 790 (67) 0.08
Cardiac morbidityc 157 (30) 215 (18) <0.001
Pulmonary morbidityc 123 (23) 153 (13) <0.001
Cerebral morbidityd 72 (14) 127 (11) 0.09
Cancer 28 (5) 34 (3) 0.02
Diabetes 71 (14) 105 (9) 0.006
Baseline creatinine (mmol/L) 87 (74e107) 85 (70e103) 0.1
Diagnosed renal impairment 3 (0.6) 12 (1) 0.6
Preoperative dialysis 0 4 (0.3) 0.3
ASA score <0.001
1 (class 1 þ 2) 298 (57) 928 (79)
2 (class 3 þ 4) 226 (43) 246 (21)
Duration of surgery (hours) 01:50 (01:27e02:22) 02:40 (02:06e03:20) <0.001
Blood loss (mL) 200 (100e500) 1700 (1050e2600) < 0.001
Note. Data are given as the count (percentage) and median (25th to 75th percentiles). ASA ¼ Surgical risk according to the American
Society of Anesthesiologists physical status score; EVAR ¼ endovascular aortic repair.
a As the comparison involved 15 tests, the signiﬁcant p value was lowered to 0.05/15 ¼ 0.003 according to Bonferroni.
b Smoking is deﬁned as “ever smoked”.
c Cardiac and pulmonary morbidity deﬁnes any condition requiring treatment.
d Cerebral morbidity deﬁnes cerebrovascular disease or any cerebral condition requiring treatment.
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are illustrated in Fig. 2A. To evaluate the effect of baseline
characteristics on survival we performed a Cox regression
analysis. Age (hazard ratio 2.05, CI 2.03e2.07), cardiac
morbidity (hazard ratio 1.67, CI 1.52e1.88), and ASA score
(hazard ratio 1.49, CI 1.38e1.62) had a negative effect on
survival. When adjusting for age, cardiac morbidity, and ASA
score there was no difference in all cause mortality after
EVAR vs. OR (p ¼ 0.7) (Fig. 2B).
During follow-up endoleaks requiring treatment were
seen in 23 (4.4%) of the EVAR patients; 18 were diagnosed
within the ﬁrst 12 months (Fig. 3). Aneurysm rupture
occurred in one EVAR patient (0.2%) 18 months after the
primary procedure due to an undetected type 1 endoleak.
Three anastomotic ruptures (0.26%) were recorded in theTable 2. Perioperative outcomes.
EVAR (n ¼ 525) OR (n ¼
Stay at ICU >3 days 3 (0.6) 70 (6)
General complications 41 (8) 244 (21
Surgical complications 29 (6) 139 (12
Wound complications 75 (14) 82 (7)
Acute kidney injury 13 (3) 81 (7)
Dialysis 3 (0.6) 39 (3)
Reinterventions 32 (6) 204 (18
Readmissions 68 (13) 143 (13
LOS (days) 4 (2e5) 7 (6e
30-day mortality 5 (1) 39 (3.3
Onset PAD 11 (2) 37 (3)
Note. Data are given as the count (percentage) and median (25th to 75
care unit; LOS ¼ length of stay; PAD ¼ peripheral arterial disease.
a As the comparison involved 11 tests, the signiﬁcant p value was lowOR cohort at three different centers, all within 3 months of
the primary procedure and one with fatal outcome. In total,
four EVAR patients and eight OR patients underwent major
aneurysm-related reinterventions (p ¼ 0.8) (Table 3). After
OR 10.3% developed incisional hernia, bowel obstruction
occurred in 3.4%, and 3.1% were diagnosed with bowel
ischemia. One incidence of bowel ischemia in relation to a
prosthesis infection was recorded in the EVAR cohort, but
no incisional hernias or cases with bowel obstruction were
recorded (Table 3). Of the 121 patients diagnosed with an
incisional hernia 71 (6%) were treated surgically; regarding
bowel obstruction 27 out of 40 patients diagnosed were
operated (2.3%). In the OR cohort 89% of the cases of
bowel ischemia were seen in the perioperative period and
treated without exception.1176) p Valuea Relative risk associated
with open repair (95% CI)
<0.001 10.42 (3.29e32.93)
) <0.001 2.66 (1.94e3.64)
) <0.001 2.14 (1.45e3.15)
<0.001 0.49 (0.36e0.66)
<0.001 2.78 (1.56e4.95)
<0.001 5.80 (1.80e18.69)
) <0.001 2.85 (1.99e4.07)
) 0.6 0.94 (0.72e1.23)
9) <0.001
) 0.004 3.48 (1.38e8.78)
0.3 1.50 (0.77e2.92)
th percentiles). EVAR ¼ endovascular aortic repair; ICU ¼ intensive
ered to 0.05/11 ¼ 0.005 according to Bonferroni.
Table 3. Follow-up (0e57 months).
EVAR (n ¼ 525) OR (n ¼ 1176) p Value Relative risk associated
with open repair (95% CI)
Dialysis >12 months 1 (0.2) 4 (0.3) 1.0 1.79 (0.20e15.94)
Endoleak 23 (4) e e
Bowel ischemia 1 (0.2) 37 (3) <0.001 16.52 (2.27e120.07)
Bowel obstruction 0 40 (3) <0.001 a
Incisional hernia e 121 (10) e
Other abdominal complication 0 6 (0.5) 0.1 a
AAA sac rupture 1 (0.2) e e
Anastomotic rupture e 3 (0.3) e
Graft-enteric ﬁstula 0 1 (0.1) 0.5 a
Prosthesis infection 3 (0.6) 11 (0.9) 0.5 1.64 (0.46e5.84)
Major aneurysm-related intervention 4 (0.8) 8 (0.7) 0.9 0.89 (0.27e2.95)
Note. Data are given as the count (percentage). AAA ¼ abdominal aortic aneurysm; EVAR ¼ endovascular aortic repair.
a Value not attainable.
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and regarding OR 61% of the procedures were performed
outside the university clinics (UNI). However, there was no
difference in 30-day mortality (UNI OR 3.1% vs. other ORA
B
Figure 2. KaplaneMeier plots of survival (A) and survival function
after correction for age, cardiac morbidity, and American Society of
Anesthesiologists score (B) according to type of aneurysm repair.3.5%, p ¼ 0.7), general or wound complications. Surgical
complications were more frequent in the non-university
centers (UNI OR 10% vs. other OR 15%, p ¼ 0.008).
If we only compare data from the university clinics on
EVAR and OR, results are the same as nationwide: general
complications, UNI EVAR 8% vs. UNI OR 24% (p < 0.001);
surgical complications, UNI EVAR 6% vs. UNI OR 10%
(p ¼0.01); wound complications, UNI EVAR 14% vs. UNI OR
7% (p < 0.001); reinterventions, UNI EVAR 6% vs. UNI OR
16% (p< 0.001); and 30-day mortality, UNI EVAR 1% vs. UNI
OR 3.1% (p ¼ 0.02) (see Table 2 for comparisons).DISCUSSION
This study shows a signiﬁcant perioperative beneﬁt of EVAR
over OR for elective repair. Like previous studies,2,4,15 we
found that EVAR was associated with fewer major compli-
cations, a shorter length of stay, and lower perioperative
mortality than OR.
Because of the non-random assignment to EVAR vs. OR in
this cohort study, the results cannot be compared with the
results from RCTs. Where the limitations to randomizedFigure 3. KaplaneMeier plot of freedom from endoleak requiring
treatment in the endovascular aortic repair cohort.
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treatments the historical cohorts like ours are limited due to
selection bias regarding aneurysm anatomy, patient co-
morbidity, and age. Another limitation related to historical
register data is the possible underestimation of numbers.
Although the Danish Vascular Registry is a validated data-
base, the recordings for some parameters could be incon-
sistent and potentially resemble minimum ﬁgures. Speciﬁc
limitations related to our data are the missing information
on AAA diameter and location, procedure-speciﬁc infor-
mation on clamping, additional stenting of visceral arteries
and occlusion of the hypogastric artery, and follow-up in-
formation on endoleaks regardless of the need for inter-
vention. Many of these parameters have been added to the
Danish Vascular Registry after 2009 but are not reported in
our study since the data were not registered for all the
patients treated during 2007e2009.
The vascular surgery service in Denmark is organized to
secure sufﬁcient volume and proﬁciency. All departments
perform a minimum of procedures, and based on mortality
and complication rates in the university clinics versus non-
university clinics we are conﬁdent that there is no major
center effect. This is supported by the ﬁnding that results on
EVAR versus OR based on data from university clinics alone
are similar to nationwide results.
Regarding late results we have a follow-up period similar
to the large registry study performed by Schermerhorn
et al.2 on Medicare beneﬁciaries in the USA. By comparing
data from the Danish Vascular Registry and the Danish
National Patient Register we have obtained 100% validation
of the ﬁgures on readmissions, reinterventions, and
mortality.
Compared with Medicare beneﬁciaries, Danish patients
were on average younger (EVAR 74 and OR 70 years vs.
Medicare 76 years), Danish EVAR patients were more often
males (90% vs. 80%) and discharged later (LOS 4.3 days vs.
3.4 days).2 However, the Danish OR patients were dis-
charged earlier than the OR patients in the Medicare study
(7 days vs. 9 days) and more often discharged home than
the OR patients in the Medicare study (89% vs. 82%).2 The
rate of primary conversion from EVAR to OR was signiﬁ-
cantly lower in our study than in the study by Schermerhorn
et al. (0.4% vs. 1.6%), which might reﬂect the increased
endovascular experience and technical improvements ob-
tained in the time between the two studies.
Thirty-day mortality in the Danish cohort (EVAR 1% vs.
OR 3.3%) was similar to the Medicare results (EVAR 1.2% vs.
OR 4.8%), and in the long term the overall survival curves
after EVAR and OR crosses within 2e4 years as both RCTs
and previous registry studies have shown. We could not
conﬁrm the advantage in long-term survival after EVAR vs.
OR reported by Jackson et al.,8 but when adjusting for age,
cardiac morbidity, and ASA score we found no difference in
survival after the two procedures, which is similar to pre-
vious ﬁndings.16e18
Similar to other register studies,2,19 we found higher rates
of AKI and dialysis after OR than after EVAR in the peri-
operative period, notably with no difference in preoperativerenal status. However, aneurysm location is a possible
confounder since juxtarenal AAA may be associated with a
higher rate of AKI and is more likely to be treated by OR.
The assessment of acute renal injury in the Danish Vascular
Registry relies on a vague deﬁnition which represents an
obstacle in the reporting of AKI. This possibly leads to un-
derestimation of acute renal impairment, whereas the rate
of acute renal failure requiring dialysis is reliable. However,
the assumed underestimation affects both OR and EVAR
and presumably reﬂects the right proportion between the
rates of AKI and dialysis in the two groups. Further analysis
indicated that perioperative dialysis was associated with
high mortality rates, comparable to previous studies,20,21
and a notable risk of continuous dialysis after 3 months.
However, remission from dialysis is possible within the ﬁrst
year (3 out of the 7 OR patients gained remission).
Groin incisions are more prone to infectious complica-
tions than abdominal incisions, and by comparing the open
aortobifemoral procedures to the EVAR procedures we
found similar rates of wound complications. Nevertheless,
the high rate of wound-related complications requires
improvement.
The ﬁrst randomized trials on OR vs. EVAR reported
signiﬁcantly higher rates of aneurysm-related complications
and reinterventions after EVAR than after OR7,22 but lacked
data on laparotomy-related complications and reinterven-
tions. Although the OVER trial supplied insight on this
aspect by showing equal frequencies of aneurysm-related
complications after EVAR and laparotomy-related compli-
cations after OR3 controversy persists regarding the beneﬁts
of EVAR compared with OR due to late aneurysm-related
complications.
Fig. 3 illustrates the time-dependency of endoleaks. The
vast majority of endoleaks in our study occurred within the
ﬁrst 12 months, no new endoleaks were diagnosed after 3
years, and our data show a concentration of diagnoses
concurrent with the routine imaging. Comparison of results
on endoleaks is difﬁcult. We report endoleaks requiring
treatment (4.4%), whereas Schermerhorn et al.2 reported
6.7% in need of minor endovascular reintervention and
1.1% in need of open aneurysm repair but not the indica-
tion for intervention. Considering the difference in how
data are reported, a signiﬁcantly lower rate of endoleaks
might reﬂect the improvements in stent graft design and
deployment proﬁciency. However, you also have to take into
account the change in indication for treatment of endoleak
which has occurred over time. In the early days type 2
endoleaks were often treated, whereas nowadays the
approach is predominantly watchful waiting. However, since
type of endoleak is not consistently recorded in the Danish
Vascular Registry we cannot verify this assumption.
The rupture rate for the Danish EVAR cohort was 0.2%
compared with 1.8% in the Medicare cohort2 and 0.7% in
the Lifeline Registry.17 This is possibly an underestimation
since we have far from a 100% autopsy rate in Denmark.
However, this is true for most countries and therefore a
general condition in the assessment of aneurysm-related
mortality and rupture rates after both EVAR and OR.
L. de la Motte et al. 63Therefore, the low rupture rate in our cohort should be
proportionally reliable and might again reﬂect the im-
provements in the endovascular treatments. Rupture as
such does not exist after OR since the aneurysm sac is not
preserved. However, anastomotic ruptures do occur after
OR and are comparable in severity to aneurysm sac rupture.
We recorded equal frequencies of the two types of rupture
in the respective Danish cohorts and the rate of rupture
after OR in Denmark is also comparable to the Medicare
result (0.3% vs. 0.5%).
Our study supports the ﬁndings in the OVER trial3 and the
Medicare study2 regarding procedure-related complica-
tions. During the entire follow-up period the Danish OR
cohort had a higher total rate of procedure-related com-
plications than the EVAR cohort. This was mainly due to
laparotomy-related complications, but contrary to the
Medicare study2 we found similar rates of rupture, graft-
enteric ﬁstula, prosthesis infection, and major aneurysm-
related reintervention between the two groups. Also,
bowel ischemia was signiﬁcantly more frequent after OR
than EVAR.
It could be argued that aneurysm-related outcomes are
the only relevant parameters after aneurysm repair. How-
ever, if a treatment option results in a relatively low rate of
aneurysm-related complications but a high total frequency
of procedure-related complications it might be worth
considering the alternative less invasive treatment option
with the higher but still not alarming rate of aneurysm-
related complications, especially considering that the vast
majority of these complications can be treated by minor
endovascular reintervention.CONCLUSION
Outcomes after endovascular repair of asymptomatic AAA
in Denmark between 2007 and 2010 are comparable with
international observations and generally better than the
results after open surgery for AAA in Denmark. Similar to
previous register studies, the EVAR population were older
and more comorbid but despite this showed similar long-
term survival to the younger and healthier OR population.
Contrary to previous ﬁndings we found similar rates of
rupture and major aneurysm-related reinterventions after
the two procedures, and seen in the light of the higher rate
of procedure-related reinterventions after open surgery
EVAR seems more tempting for all patients who are
anatomically ﬁt. However, it should be borne in mind that
more complex aneurysms most likely underwent open
surgery, which might explain the higher rate of, for example,
AKI after OR. Finally, we believe there is room for optimi-
zation of the minimally invasive endovascular procedure to
reduce wound complications, reinterventions, and length of
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